Bioequivalence Study Between YHP1906 Tab. 5 mg and YHR1902 Tab. 5 mg
Clinical trial NCT04316065 · COMPLETED
Trial details
- NCT number
- NCT04316065
- Sponsor
- Yuhan Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-11
- Primary completion
- 2020-04-20
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.